ARTICLE | Clinical News

Celebrex celecoxib: Marketed to treat osteoarthritis (OA) and adult rheumatoid arthritis (RA)

November 6, 2000 8:00 AM UTC

PHA and partner Pfizer Inc. (PFE, New York, N.Y.) presented data from a 6-week, 246-patient placebo-controlled study in France showing that a twice daily 100 mg dose of Celebrex gave significantly su...